Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Meeting of the Minds: Send Your Stories.

Albaugh JF, Haywood JR, Jefferies JA, Yatagai T.

Physiologist. 2015 Sep;58(5):266-7. No abstract available.

PMID:
26442384
2.

Meeting of the minds: Send your stories.

Albaugh JF, Haywood JR, Jefferies JA, Yatagai T.

Science. 2015 Jul 10;349(6244):148-9. doi: 10.1126/science.349.6244.148-a. Epub 2015 Jul 9. No abstract available.

PMID:
26160935
3.

Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia.

Pachman DR, Barton DL, Clayton AC, McGovern RM, Jefferies JA, Novotny PJ, Sloan JA, Loprinzi CL, Gostout BS.

Am J Obstet Gynecol. 2012 Jan;206(1):42.e1-7. doi: 10.1016/j.ajog.2011.06.105. Epub 2011 Jul 13.

4.

A randomized trial of interferon-alpha in cervical dysplasia.

Gostout BS, Hartmann LC, Suman VJ, Fay NE, Jefferies JA, Morton RF, Gaffey TA, Farr GH Jr, Tschetter LK, Abu-Ghazaleh S, Gallenberg MM, Hatfield AK.

Int J Gynaecol Obstet. 2001 Aug;74(2):207-10. No abstract available.

PMID:
11502303
5.

Low-grade endometrial stromal sarcoma of the ectocervix after therapy for breast cancer.

Boardman CH, Webb MJ, Jefferies JA.

Gynecol Oncol. 2000 Oct;79(1):120-3.

PMID:
11006043
6.

Granulocyte-macrophage colony-stimulating factor. Preliminary observations on the influences of dose, schedule, and route of administration in patients receiving cyclophosphamide and carboplatin.

Edmonson JH, Hartmann LC, Long HJ, Colon-Otero G, Fitch TR, Jefferies JA, Braich TA, Maples WJ.

Cancer. 1992 Nov 15;70(10):2529-39.

PMID:
1423182
7.

Evaluation of treatment and survival after positive second-look laparotomy.

Podratz KC, Schray MF, Wieand HS, Edmonson JH, Jefferies JA, Long HJ, Malkasian GD, Stanhope CR, Wilson TO.

Gynecol Oncol. 1988 Sep;31(1):9-24.

PMID:
3410358
8.

Phase II studies of bleomycin, cyclophosphamide, doxorubicin and cisplatin, and bleomycin and cisplatin in advanced cervical carcinoma.

Edmonson JH, Johnson PS, Wieand HS, Malkasian GD, Cullinan SA, Brown LD, Mailliard JA, Jefferies JA.

Am J Clin Oncol. 1988 Apr;11(2):149-51.

PMID:
2451883
9.

Randomized phase II studies of cisplatin and a combination of cyclophosphamide-doxorubicin-cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinoma.

Edmonson JH, Krook JE, Hilton JF, Malkasian GD, Everson LK, Jefferies JA, Mailliard JA.

Gynecol Oncol. 1987 Sep;28(1):20-4.

PMID:
3653766
10.

Pilot study of cyclophosphamide plus carboplatin in advanced ovarian carcinoma.

Edmonson JH, McCormack GW, Krook JE, Long HJ, Jefferies JA, Richardson RL.

Cancer Treat Rep. 1987 Feb;71(2):199-200.

PMID:
3542210
11.

Comparison of cyclophosphamide plus cisplatin versus hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin in combination as initial chemotherapy for stage III and IV ovarian carcinomas.

Edmonson JH, McCormack GW, Fleming TR, Cullinan SA, Krook JE, Malkasian GD, Podratz KC, Mailliard JA, Jefferies JA, Barlow JF, et al.

Cancer Treat Rep. 1985 Nov;69(11):1243-8.

PMID:
3937598
12.

Effects of progestational agents in treatment of endometrial carcinoma.

Podratz KC, O'Brien PC, Malkasian GD Jr, Decker DG, Jefferies JA, Edmonson JH.

Obstet Gynecol. 1985 Jul;66(1):106-10.

PMID:
4011061
13.

Upper genital tract abnormalities and pregnancy outcome in diethylstilbestrol-exposed progeny.

Kaufman RH, Noller K, Adam E, Irwin J, Gray M, Jefferies JA, Hilton J.

Am J Obstet Gynecol. 1984 Apr 1;148(7):973-84.

PMID:
6711635
14.

Structural anomalies of the cervix and vagina in women enrolled in the Diethylstilbestrol Adenosis (DESAD) Project.

Jefferies JA, Robboy SJ, O'Brien PC, Bergstralh EJ, Labarthe DR, Barnes AB, Noller KL, Hatab PA, Kaufman RH, Townsend DE.

Am J Obstet Gynecol. 1984 Jan 1;148(1):59-66.

PMID:
6691382
15.

Maturation of vaginal and cervical epithelium in women exposed in utero to diethylstilbestrol (DESAD Project).

Noller KL, Townsend DE, Kaufman RH, Barnes AB, Robboy SJ, Fish CR, Jefferies JA, Bergstralh EJ, O'Brien PC, McGorray SP, Scully R.

Am J Obstet Gynecol. 1983 Jun 1;146(3):279-85.

PMID:
6859137
16.

Treatment of recurrent and metastatic carcinoma of the cervix: comparison of doxorubicin with a combination of vincristine and 5-fluorouracil.

Malkasian GD Jr, Decker DG, Green SJ, Edmonson JH, Jefferies JA, Webb MJ.

Gynecol Oncol. 1981 Apr;11(2):235-9. No abstract available.

PMID:
7011913
17.

Different chemotherapeutic sensitivities and host factors affecting prognosis in advanced ovarian carcinoma versus minimal residual disease.

Edmonson JH, Fleming TR, Decker DG, Malkasian GD, Jorgensen EO, Jefferies JA, Webb MJ, Kvols LK.

Cancer Treat Rep. 1979 Feb;63(2):241-7.

PMID:
445503
18.

Chemotherapeutic sensitivity of minimal residual disease following surgical excision of ovarian carcinoma.

Edmonson JH, Fleming TR, Decker DG, Jorgensen EO, Malkasian GD, Jefferies JA, Kvols LK, Webb MJ.

Recent Results Cancer Res. 1978;68:157-9. No abstract available.

PMID:
752853
19.

The retained cervical stump. A 25-year experience.

Pratt JH, Jefferies JA.

Obstet Gynecol. 1976 Dec;48(6):711-5.

PMID:
995341

Supplemental Content

Loading ...
Support Center